Amgen s interchangeable Soliris biosimilar Bkemv approved by FDA for rare blood disorders pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
USFDA gives nod to first interchangeable biosimilar for two rare diseases financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
THOUSAND OAKS (dpa-AFX) - The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British
Biosimilar for 2 Rare Diseases Accepted by FDA zenopa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zenopa.com Daily Mail and Mail on Sunday newspapers.
FDA Approves First Interchangeable Biosimilar to Eculizumab for PNH and aHUS hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.